Quay Pharmaceuticals provides a comprehensive outsourcing service for the development and clinical manufacture of pharmaceutical products. Quay Pharma has particular expertise in the development of new chemical entities that exhibit poor solubility and bio-availability supporting their clients through to successful licensing deals.
  • Pre-formulation
  • Formulation development
  • Analytical method development and contract analysis
    (including stability testing to ICH guidelines)
  • Manufacture of clinical trial supplies


Quay is headed by Prof. Mike Rubinstein, who has over 30 years experience in pharmaceutical dosage form design, development and manufacturing.